Markham, Anthony; Adkins, Julie C. - In: PharmacoEconomics 18 (2000) 6, pp. 591-608
Cost estimates from developed countries indicate that asthma accounts for up to 2% of the economic cost of all diseases. A large proportion of asthma-related costs are attributable to poor asthma control. Treatment strategies which improve clinical outcomes in patients with asthma, therefore,...